Literature DB >> 32301141

With great power comes great… reliability.

Boback Ziaeian1,2, Javed Butler3, Gregg C Fonarow2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32301141      PMCID： PMC7665165          DOI： 10.1002/ejhf.1816

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   17.349


× No keyword cloud information.
  15 in total

Review 1.  Efficient design of clinical trials and epidemiological research: is it possible?

Authors:  Michael S Lauer; David Gordon; Gina Wei; Gail Pearson
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

Review 2.  Adaptive Designs for Clinical Trials.

Authors:  Deepak L Bhatt; Cyrus Mehta
Journal:  N Engl J Med       Date:  2016-07-07       Impact factor: 91.245

3.  Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?

Authors:  E W Steyerberg; P M Bossuyt; K L Lee
Journal:  Am Heart J       Date:  2000-05       Impact factor: 4.749

4.  Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.

Authors:  John J V McMurray; Alice M Jackson; Carolyn S P Lam; Margaret M Redfield; Inder S Anand; Junbo Ge; Marty P Lefkowitz; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Adel R Rizkala; Shalini V Sabarwal; Amil M Shah; Sanjiv J Shah; Victor C Shi; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Maja Cikes; Eva Goncalvesova; Tzvetana Katova; Anamaria Kosztin; Malgorzata Lelonek; Nancy Sweitzer; Orly Vardeny; Brian Claggett; Pardeep S Jhund; Scott D Solomon
Journal:  Circulation       Date:  2019-11-17       Impact factor: 29.690

5.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 6.  Cardiac amyloidosis: An underdiagnosed/underappreciated disease.

Authors:  Antonis S Manolis; Antonis A Manolis; Theodora A Manolis; Helen Melita
Journal:  Eur J Intern Med       Date:  2019-07-30       Impact factor: 4.487

7.  The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial.

Authors:  Timothy J Collier; Stuart J Pocock; John J V McMurray; Faiez Zannad; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Bertram Pitt
Journal:  Eur Heart J       Date:  2013-07-17       Impact factor: 29.983

8.  Mega-trials in heart failure: effects of dilution in examination of new therapies.

Authors:  Beth A Davison; Koji Takagi; Stefanie Senger; Gary Koch; Marco Metra; Antoine Kimmoun; Alexandre Mebazaa; Adriaan A Voors; Olav W Nielsen; Ovidiu Chioncel; Peter S Pang; Barry H Greenberg; Aldo P Maggioni; Alain Cohen-Solal; Georg Ertl; Naoki Sato; John R Teerlink; Gerasimos Filippatos; Piotr Ponikowski; Etienne Gayat; Christopher Edwards; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2020-03-30       Impact factor: 15.534

9.  Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HF.

Authors:  Joanne Simpson; Pardeep S Jhund; Jose Silva Cardoso; Felipe Martinez; Arend Mosterd; Felix Ramires; Adel R Rizkala; Michele Senni; Iain Squire; Jianjian Gong; Martin P Lefkowitz; Victor C Shi; Akshay S Desai; Jean L Rouleau; Karl Swedberg; Michael R Zile; John J V McMurray; Milton Packer; Scott D Solomon
Journal:  J Am Coll Cardiol       Date:  2015-11-10       Impact factor: 24.094

10.  Characteristics and Treatments of Patients Enrolled in the CHAMP-HF Registry Compared With Patients Enrolled in the PARADIGM-HF Trial.

Authors:  Adam D DeVore; Xiaojuan Mi; Laine Thomas; Puza P Sharma; Nancy M Albert; Javed Butler; Adrian F Hernandez; J Herbert Patterson; John A Spertus; Fredonia B Williams; Carol I Duffy; Kevin McCague; Gregg C Fonarow
Journal:  J Am Heart Assoc       Date:  2018-06-12       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.